Resultados de la búsqueda 231-240 of 9385 for Low-Dose Naltrexone
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
Alternate Doses And Dosing ... The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose ... low or high risk ...
Reduced Dose Hypofractionated Radiotherapy For Indolent Non-hodgkin Lymphoma. Rochester, Minn., La Crosse, Wis., Mankato, Minn., Eau Claire, Wis ...
The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose ... small cell lung cancer and small cell lung ...
The purpose of this study is to find out more about the side effects of the CAR-T therapy called IC19/1563 and what dose of IC19/1563 is safe for patients.
This gene allows the T cells to recognize and possibly treat the cancer. The new modified T cells are called the IC19/1563 treatment. The dose of IC19/1563 will ...
... Dose Expansion Phase (Part B) of CA-4948 in ... Chemotherapy For The Treatment Of Patients With Newly Diagnosed Very Low-Risk And Low Risk Fusion Negative ...
The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...
... dose levels without altering contrast-to-noise, and to improve discrimination of very small structures using the system's increased spatial resolution.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?